Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 403 institutions that hold shares in the stock, with a total of 37.3 Million shares, which have been reported (via 13F filing form) to have a value of $4.82 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,945,020
shares
|
$496 Million
0.01% of portfolio
|
Q2 2025
Added 1.76%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,299,991
shares
|
$415 Million
0.01% of portfolio
|
Q2 2024
Added 3.27%
|
|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,690,221
shares
|
$212 Million
6.93% of portfolio
|
Q1 2025
Added 21.77%
|
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,516,903
shares
|
$191 Million
2.43% of portfolio
|
Q2 2025
Reduced 48.1%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
1,137,748
shares
|
$143 Million
0.15% of portfolio
|
Q2 2025
Added 16.54%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
989,453
shares
|
$124 Million
0.01% of portfolio
|
Q2 2025
Added 5.84%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
958,503
shares
|
$120 Million
0.0% of portfolio
|
Q2 2025
Added 5.79%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Aug 14, 2025 Q2 2025 |
815,176
shares
|
$102 Million
26.09% of portfolio
|
Q1 2025
Reduced 44.51%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
801,371
shares
|
$101 Million
2.97% of portfolio
|
Q2 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
753,429
shares
|
$94.7 Million
0.01% of portfolio
|
Q2 2025
Added 41.12%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
725,672
shares
|
$91.2 Million
1.44% of portfolio
|
Q2 2025
Reduced 2.57%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
725,044
shares
|
$91.1 Million
0.01% of portfolio
|
Q2 2025
Added 3.09%
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
667,368
shares
|
$83.9 Million
56.0% of portfolio
|
Q1 2025
Reduced 9.12%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
612,743
shares
|
$77 Million
0.01% of portfolio
|
Q2 2025
Added 1816.2%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
595,455
shares
|
$74.8 Million
0.01% of portfolio
|
Q2 2025
Added 106.29%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
571,549
shares
|
$71.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 33.31%
|
|
|
Man Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
525,069
shares
|
$66 Million
0.11% of portfolio
|
Q2 2025
Added 2.31%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
483,105
shares
|
$60.7 Million
4.79% of portfolio
|
Q2 2025
Reduced 13.2%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
468,329
shares
|
$58.9 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
463,842
shares
|
$58.3 Million
0.04% of portfolio
|
Q2 2023
Added 13921.83%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
447,919
shares
|
$56.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.08%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
447,000
shares
|
$56.2 Million
0.08% of portfolio
|
Q2 2025
Added 831.25%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
427,900
shares
|
$53.8 Million
1.59% of portfolio
|
Q2 2025
Added 10.65%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
411,850
shares
|
$51.8 Million
0.05% of portfolio
|
Q2 2025
Added 23.6%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
409,394
shares
|
$51.5 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.38%
|